Advertisement

Topics

Genes may cause tumor aggressiveness, drug resistance in African-American prostate cancer

10:07 EDT 30 Jun 2017 | Science Daily

A form of genetic variation, called differential RNA splicing, may have a role in tumor aggressiveness and drug resistance in African-American men with prostate cancer, according to research.

Original Article: Genes may cause tumor aggressiveness, drug resistance in African-American prostate cancer

NEXT ARTICLE

More From BioPortfolio on "Genes may cause tumor aggressiveness, drug resistance in African-American prostate cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...